<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02170467</url>
  </required_header>
  <id_info>
    <org_study_id>2012/174/HP</org_study_id>
    <nct_id>NCT02170467</nct_id>
  </id_info>
  <brief_title>Study of Intestinal Permeability in Patients With Anorexia Nervosa</brief_title>
  <acronym>PIANO</acronym>
  <official_title>Study of Intestinal Permeability in Patients With Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In healthy humans, the intestinal mucosa acts as an absorption organ and a defensive barrier&#xD;
      preventing the passage of toxic substances from the intestinal lumen to the blood stream.&#xD;
      Malnutrition and absence of exogenous luminal nutrients in the gastrointestinal tract&#xD;
      profoundly affect small bowel morphology and physiology. Many reports have described&#xD;
      alterations of ion and nutrient transport, mucosal atrophy and modifications in the&#xD;
      intestinal permeability to macromolecules in cases of prolonged intestinal rest, as in severe&#xD;
      starvation. These changes may dampen both the absorptive and the barrier functions of&#xD;
      intestinal mucosa.&#xD;
&#xD;
      The assessment of intestinal permeability, by measuring the urinary excretion of substances&#xD;
      that are not metabolised by human tissues and passively cross the intestinal epithelium, is a&#xD;
      reliable and non invasive method to investigate the anatomo-functional integrity of the&#xD;
      intestinal mucosa. Previous studies have shown an increase of permeability in malnourished&#xD;
      humans . The increase of may also increase the risk for inappropriate passage of food&#xD;
      antigens and other noxious substances across the mucosal barrier. To this regard, the&#xD;
      enhanced susceptibility of malnourished subjects to systemic infections and postoperative&#xD;
      sepsis has long been recognised.&#xD;
&#xD;
      Anorexia nervosa is a psychiatric disorder characterised by abnormal eating behaviours aiming&#xD;
      to decrease body weight. Typically, women with anorexia nervosa restrict food ingestion up to&#xD;
      severe starvation. These behaviours usually lead to malnutrition and a more or less prolonged&#xD;
      absence of luminal nutrients in the gastrointestinal tract. Therefore, alterations in the&#xD;
      integrity and functioning of intestinal mucosa are likely to occur in this condition. There&#xD;
      is no information on intestinal permeability in patients with eating disorders. We&#xD;
      hypothesised that, as it occurs in simple starvation and malnutrition, intestinal&#xD;
      permeability should be increased in fasted undernourished people with anorexia nervosa and&#xD;
      decrease after re feeding. Therefore, in the present study, we explored intestinal&#xD;
      permeability of 23 subjects with anorexia nervosa by means of the lactulose-mannitol test and&#xD;
      urinary sucralose excretion and compare them to 46 controls.&#xD;
&#xD;
      Moreover, auto-antibodies (α-MSH ) have been found in patients with anorexia nervosa. The&#xD;
      origin of these auto-antibodies is still unknown , but some studies suggested a digestive&#xD;
      origin. Moreover, modifications of intestinal flora have been described in patients with&#xD;
      anorexia nervosa. Actually, a study of the intestinal barrier of patients with anorexia&#xD;
      nervosa is necessary. In this study, a comparaison of intestinal permeability and&#xD;
      autoantibodies (α-MSH) rate is proposed before and after re-feeding in patients with anorexia&#xD;
      nervosa.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 5, 2015</start_date>
  <completion_date type="Actual">May 3, 2018</completion_date>
  <primary_completion_date type="Actual">May 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% of Sugar urinary excretion</measure>
    <time_frame>From day 1 to Day 17, assessment after a 10% weight gain under renutrition</time_frame>
    <description>intestinal permeability test - oral intake of lactulose - mannitol - sucralose</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sucralose urinary sampling</measure>
    <time_frame>From day 1 to Day 17, assessment after a 10% weight gain under renutrition</time_frame>
    <description>colon permeability assessement</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Evolution of auto-antibodies level ((a-MSH) after re-feeding in patients with anorexia nervosa</measure>
    <time_frame>Day 1</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of intestinal permeability in small intestine (Lactulose/ Mannitol ratio) in controls and camparison with pateints with anorexia nervosa.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with anorexia nervosa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of intestinal permeability in small intestine (Lactulose/ Mannitol ratio) in patients with anorexia nervosa before and after re-feeding.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>assessment of the intestinal permeability</intervention_name>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>patients with anorexia nervosa</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with anorexia nervosa :&#xD;
&#xD;
          -  female,&#xD;
&#xD;
          -  living in Upper Normandy since 1 year at least,&#xD;
&#xD;
          -  between 18 and 50 years of age&#xD;
&#xD;
          -  with a BMI between 14 and 16 kg/m²,&#xD;
&#xD;
          -  diagnosed as anorexia nervosa according to the DSM IV criteria&#xD;
&#xD;
          -  hospitalised for the first time in the Nutrition Unit&#xD;
&#xD;
          -  not being pregnant (effective contraception and negative pregnancy test)&#xD;
&#xD;
          -  not breast-feeding,&#xD;
&#xD;
          -  HIV-1 negative ,&#xD;
&#xD;
          -  HIV-2 negative,&#xD;
&#xD;
          -  HBV negative (hépatitis B virus),&#xD;
&#xD;
          -  HCV negative (hépatitis C virus),&#xD;
&#xD;
          -  Affiliated to the National Health Service,&#xD;
&#xD;
          -  Giving a filled informed consent,&#xD;
&#xD;
          -  Not included in other studies&#xD;
&#xD;
        Controls :&#xD;
&#xD;
          -  female,&#xD;
&#xD;
          -  living in Upper Normandy since 1 year at least,&#xD;
&#xD;
          -  between 18 and 50 years of age,&#xD;
&#xD;
          -  with a BMI between 20 and 24,9 kg/m²,&#xD;
&#xD;
          -  without antecedent or current diagnosis of eating disorders (DSM IV criteria),&#xD;
&#xD;
          -  without dyspepsia or irritable bowel syndrom for 6 month,&#xD;
&#xD;
          -  not being pregnant (effective contraception and negative pregnancy test)&#xD;
&#xD;
          -  not breast-feeding,&#xD;
&#xD;
          -  HIV-1 negative ,&#xD;
&#xD;
          -  HIV-2 negative,&#xD;
&#xD;
          -  HBV negative (hépatitis B virus),&#xD;
&#xD;
          -  HCV negative (hépatitis C virus),&#xD;
&#xD;
          -  Affiliated to the National Health Service,&#xD;
&#xD;
          -  Giving a filled informed consent,&#xD;
&#xD;
          -  Not included in other studies&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients with anorexia nervosa :&#xD;
&#xD;
          -  Adult under guardianship,&#xD;
&#xD;
          -  Patient with inflammatory bowel disease and/or psychotic disorders,&#xD;
&#xD;
          -  Antecedent of digestive surgery,&#xD;
&#xD;
          -  Drug addiction for the last 6 month,&#xD;
&#xD;
          -  Alcohol and/or other substance use disorder,&#xD;
&#xD;
          -  Current immunological treatment, and/or non steroidal anti inflamatory and/or&#xD;
             corticosteroids and/or anticoagulants and/or platelet antiaggregants&#xD;
&#xD;
          -  galactosemia&#xD;
&#xD;
          -  Lactulose intolerance,&#xD;
&#xD;
          -  Laxatives intake in the last 3 days&#xD;
&#xD;
          -  Antecedent of digestive surgery,&#xD;
&#xD;
        Controls :&#xD;
&#xD;
          -  Adult under guardianship,&#xD;
&#xD;
          -  Patient with inflammatory bowel disease and/or psychotic disorders,&#xD;
&#xD;
          -  Antecedent of digestive surgery,&#xD;
&#xD;
          -  Drug addiction for the last 6 month,&#xD;
&#xD;
          -  Alcohol and/or other substance use disorder,&#xD;
&#xD;
          -  Current immunological treatment, and/or non steroidal anti inflamatory and/or&#xD;
             corticosteroids and/or anticoagulants and/or platelet antiaggregants&#xD;
&#xD;
          -  galactosemia&#xD;
&#xD;
          -  Lactulose intolerance,&#xD;
&#xD;
          -  Laxatives intake in the last 3 days&#xD;
&#xD;
          -  Antecedent of digestive surgery,&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastien GRIGIONI, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU-Hôpitaux de Rouen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital de la Croix Rouge</name>
      <address>
        <city>Bois Guillaume</city>
        <zip>76233</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU- Hôpitaux de Rouen</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>April 3, 2014</study_first_submitted>
  <study_first_submitted_qc>June 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2014</study_first_posted>
  <last_update_submitted>October 23, 2019</last_update_submitted>
  <last_update_submitted_qc>October 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intestinal permeability - Anorexia nervosa- Re feeding - auto-antibodies α-MSH</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

